FAQ: clozapine’s close checks
Clozapine, used for the management of treatment-resistant schizophrenia, is subject to strict regulatory and monitoring requirements.
Everything you need to know about the take home naloxone program
The Take Home Naloxone Pilot saved three lives every day. From Friday, free naloxone will be accessible to all Australians in need.
Regulation changes allow more pharmacist-administered vaccines
Two east coast states have made recent vaccine legislation updates, expanding community access through barrier removal.
Pharmacists supporting patients with palliative care needs
For many, the last 12 months of life is spent with significant disability, associated with rising symptom burden and functional decline. A palliative approach...
Difficult patients: Calming the storm
Dealing with aggressive or abusive patients is one of the least pleasant components of a community pharmacist’s role. What’s best practice for avoiding or...
Active ingredient prescribing mandated
From 1 February 2021, medicines will be prescribed by active ingredient on all Pharmaceutical Benefits Scheme (PBS) prescriptions.
